Sanofi collaborates with Biomunex to develop antibody therapeutics

15-01-2019

Sanofi collaborates with Biomunex to develop antibody therapeutics

Patricia-Dallaire / iStockphoto.com

Multinational pharmaceutical company Sanofi has entered into a licensing agreement with Paris-based biopharmaceutical company Biomunex.


Biomunex, Sanofi, antibody therapeutics, licensing and collaboration agreement, pharmaceuticals

More on this story

Sanofi in $50m oncology collaboration
19-07-2018

LSIPR